Global Biosimilars Market Research Report 2017Posted by Bharat Book on March 3rd, 2018 Bharat Book Bureau Provides the Trending Market Research Report on Global Biosimilars Market Opportunity Analysis And Industry Forecast 2017- 2023 under Life Science category. The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects. Biosimilars Market: By-Drug Class (Monoclonal Antibodies, Recombinant Hormones, Recombinant Growth Factors, Immunomodulators, Anti-Inflammatory Agents, and Others), By Application (Oncology, Blood Disorders, Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Diabetes, and Others), By Manufacturing Type (Captive and Out-sourcing), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Global Biosimilars Market Report Description: Request a free sample copy of Biosimilars Market Report @ Global Biosimilars Market: Growing demand for cost-effective medications to reduce healthcare burden is driving the market revenue growth Global biosimilars market is gaining traction in recent times owing to its cost-effective pricing in comparison with patented or branded biologics, which are generally priced higher than biologics. The adoption of cost-effective biosimilars is rising in different healthcare setups across the developed and developing countries to curtail the growing pressure on healthcare budgets. The introduction of biosimilars has even led to improved access to the premium-priced biopharmaceuticals in developing and underdeveloped markets with lesser costs. Moreover, favourable government policies to promote cost-effective biosimilars expected to drive market revenue growth over the forecast period. Increasing prevalence of several chronic diseases are expected to drive biosimilars market revenue growth over the forecast period The rising prevalence of several chronic diseases such as cancer, diabetes, cardiovascular diseases, autoimmune disease, and among others across the developed and developing economies expected to drive the market for Biosimilars Market over the forecast period. The growing demand from developing and an underdeveloped market for improved healthcare access are driving the market revenue growth over the forecast period. Moreover, several players are increasing their focus from developed markets to developing markets to tap increasingly growing market opportunity is driving the market revenue growth. For instance, according to globocan cancer statistics, There were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide. Europe emerged as prominent region for Biosimilars market across the globe Europe market expected to hold the higher revenue share in global biosimilars market owing to healthcare practitioners shift to low priced drugs, and wider treatment choices available in the region. Asia-pacific biosimilars market projected to grow at highest CAGR over the forecast period in comparison with other regions owing to large out-of-pocket healthcare expenditure and large medical unmet need due to lack of patented product availability. Competition Assessment Key players profiled in the global Biosimilars market include: Browse our full report with Table of Contents : About Bharat Book Bureau: Contact us at: Follow us on : Twitter, Facebook, LinkedIn, Google Plus Like it? Share it!More by this author |